CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $271.05M, lower than 95% of all stocks globally
- PositionOperating margin is -56%, lower than 95% of its Medical Instruments & Supplies peers (median 11.9%)
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
271.05MUSDvs all stocks (USD)
Revenue (TTM)
112.41MUSDvs all stocks (USD)
Profit Margin
-43.70%vs Medical Instruments & Supplies peers
Beta
0.9910xvs all stocks
52-Week Change
23.58%vs all stocks
Market Capitalization
271.05MUSDvs all stocks (USD)
Enterprise Value
122.56MUSDvs all stocks (USD)
Forward P/E
-5.95xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
2.41xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
0.8529xvs Medical Instruments & Supplies peers
Enterprise to Revenue
1.09xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
-1.99xvs Medical Instruments & Supplies peers
Gross Margin
43.46%vs Medical Instruments & Supplies peers
Profit Margin
-43.70%vs Medical Instruments & Supplies peers
Operating Margin
-55.98%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
-11.04%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
-14.07%vs Medical Instruments & Supplies peers
Revenue (TTM)
112.41MUSDvs all stocks (USD)
Revenue per Share (TTM)
1.59USDUpdated Sep 28, 2026Quarterly Revenue Growth
-1.90%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
47.93MUSDvs all stocks (USD)
EBITDA (TTM)
-61.56MUSDvs all stocks (USD)
Net Income (TTM)
-49.13MUSDvs all stocks (USD)
Operating Cash Flow (TTM)
-42.88MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-44.57MUSDvs all stocks (USD)
Payout Ratio
0.00%vs Medical Instruments & Supplies peers
Revenue
115.02MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
66.82MUSDFY2025 · Dec 31, 2025Gross Profit
48.20MUSDFY2025 · Dec 31, 2025Operating Income
-68.12MUSDvs all stocks (USD)
Pre-tax Income
-64.59MUSDFY2025 · Dec 31, 2025Income Tax Expense
1.80MUSDFY2025 · Dec 31, 2025Net Income
-68.73MUSDFY2025 · Dec 31, 2025EBIT
-68.12MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-54.31MUSDFY2025 · Dec 31, 2025Research & Development
42.53MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
73.79MUSDFY2025 · Dec 31, 2025EPS (Basic)
-0.9400USDFY2025 · Dec 31, 2025EPS (Diluted)
-0.9400USDFY2025 · Dec 31, 2025Basic Shares Outstanding
73.48MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
73.48MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-68.73MUSDFY2025 · Dec 31, 2025Operating Cash Flow
-39.91MUSDFY2025 · Dec 31, 2025Free Cash Flow
-44.11MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
199.28MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-68.73MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
9.97MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
1.85MUSDFY2025 · Dec 31, 2025Stock-based Compensation
10.15MUSDFY2025 · Dec 31, 2025Other Non-cash Items
4.58MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
1.95MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
-1.72MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
2.04MUSDFY2025 · Dec 31, 2025Capital Expenditures
-4.20MUSDFY2025 · Dec 31, 2025Net Acquisitions
-3.61MUSDFY2025 · Dec 31, 2025Purchase of Investments
0.00USDFY2025 · Dec 31, 2025Sale of Investments
0.00USDFY2025 · Dec 31, 2025Other Investing Activity
1.00MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-6.81MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-61.00KUSDFY2025 · Dec 31, 2025Common Stock Repurchase
-16.88MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-16.94MUSDFY2025 · Dec 31, 2025Shares Outstanding
68.97MSharesUpdated Sep 28, 2026Float Shares
56.95MSharesUpdated Sep 28, 2026Shares Short
3.17MSharesUpdated Sep 28, 2026Short Ratio
6.64daysvs all stocks
Short % of Shares Outstanding
4.84%vs all stocks
% Held by Insiders
6.48%vs all stocks
% Held by Institutions
89.11%vs all stocks
Total Cash (MRQ)
160.58MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
2.33USDUpdated Sep 28, 2026Total Debt (MRQ)
12.09MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.0381xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
8.88xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
4.61USDUpdated Sep 28, 2026Total Assets
403.17MUSDvs all stocks (USD)
Total Current Assets
261.91MUSDFY2025 · Dec 31, 2025Total Liabilities
62.34MUSDFY2025 · Dec 31, 2025Total Non-current Assets
141.26MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
22.55MUSDFY2025 · Dec 31, 2025Total Current Liabilities
39.80MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
199.28MUSDFY2025 · Dec 31, 2025Accounts Receivable
22.20MUSDFY2025 · Dec 31, 2025Inventory
31.06MUSDFY2025 · Dec 31, 2025Accounts Payable
6.52MUSDFY2025 · Dec 31, 2025Short-term Debt
2.23MUSDFY2025 · Dec 31, 2025Deferred Revenue
1.52MUSDFY2025 · Dec 31, 2025Other Current Liabilities
21.18MUSDFY2025 · Dec 31, 2025Long-term Debt
10.97MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
11.58MUSDFY2025 · Dec 31, 2025Common Stock (Book)
0.00USDFY2025 · Dec 31, 2025Retained Earnings
-172.16MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
340.83MUSDvs all stocks (USD)
52-Week Low
2.08USDUpdated Sep 28, 202652-Week High
4.58USDUpdated Sep 28, 202652-Week Change
23.58%vs all stocks
Beta
0.9910xvs all stocks
50-Day MA
3.77USDUpdated Sep 28, 2026200-Day MA
3.34USDUpdated Sep 28, 2026Avg 10-Day Volume
721.72KSharesUpdated Sep 28, 2026Avg 30-Day Volume
519.67KSharesUpdated Sep 28, 2026Diluted EPS (TTM)
-0.6900USDUpdated Sep 28, 2026Other Income / Expense
3.54MUSDFY2025 · Dec 31, 20251 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Cash Elevated Relative to Current Liabilities and Total Assets
Its cash covers more of its near-term bills than in its industry, and is a large share of everything it owns.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is -56%, lower than 95% of its Medical Instruments & Supplies peers (median 11.9%)Significant
Operating margin: -0.56Industry median: 0.12Industry P5: -0.14Peers compared: 62.00
Profit margin is -43.7%, lower than 95% of its Medical Instruments & Supplies peers (median 8.7%)Significant
Profit margin: -0.44Industry median: 0.09Industry P5: -0.21Peers compared: 62.00
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.43Profit Margin: -0.44
Prioritizing buybacks over growth reinvestmentNotable
Buyback Intensity: 0.06Revenue Growth YoY: -0.02
Financial Health
Altman Z-Score 2.4: grey zoneSignificant
Altman Z-Score: 2.40
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $271.05M, lower than 95% of all stocks globallySignificant
Market cap (USD): 271,046,704Global P5: 275,556,405.438
Companies that share the same coordination system — how they create, deliver, or capture value.
Unitech Computer Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Meter Instruments Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Eg Industries Bhd
Tier 1ProductionThroughput-Bound ConversionFlowRule
Huaiji Dengyun Auto Parts Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Hangzhou iEcho Science & Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Batiçim Batı Anadolu Çimento Sanayii A.Ş.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Youlchon Chemical Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Hokko Chemical Industry Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionRule
Okabe Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Jiangsu Huaxin New Material Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Heilongjiang Publishing & Media Co. Ltd.
1 interpretationCash Elevated Relative to Current Liabilities and Total Assets
Gamestop Corp.
1 interpretationCash Elevated Relative to Current Liabilities and Total Assets
Shanghai Fullhan Microelectronics Co., Ltd.
1 interpretationCash Elevated Relative to Current Liabilities and Total Assets